Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2018-04-27 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2017年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as a 2017 annual report summary for 华邦生命健康股份有限公司. It contains detailed company information, business segments, product descriptions, industry analysis, and key financial data for multiple years. The content is comprehensive and includes financial performance, business overview, and strategic outlook typical of an annual report. The length is substantial (15,000 characters), and it is not merely an announcement or a brief summary but contains substantive financial and operational data. Therefore, it fits the definition of an Annual Report (10-K). FY 2017
2018-04-27 Chinese
2017年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled "2017年度审计报告" (2017 Annual Audit Report) issued by Sichuan Huaxin (Group) CPA LLP for Huabang Life Health Co., Ltd. It contains detailed audit opinions, key audit matters, and financial statements including balance sheets, profit and loss statements, cash flow statements, and notes. The content is a standalone audit report focusing on the audit of the 2017 annual financial statements, not the full annual report itself. It includes auditor's responsibilities, management responsibilities, and detailed audit procedures, which are typical of an Audit Report. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2017
2018-04-27 Chinese
2017年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as a '2017年度监事会工作报告' which translates to '2017 Supervisory Board Work Report'. It details the supervisory board's activities, meetings, and opinions on the company's operations, financial status, internal controls, related party transactions, and insider information management for the year 2017. The content is a report from the supervisory board summarizing their oversight and work during the year, rather than a full annual report or financial statements. It is not an announcement or a brief notice but a detailed report on supervisory activities. This fits best under the category of Audit Report / Information (AR), as it relates to oversight, audit opinions, and internal control evaluations, but is not the full annual report (10-K). The document length is 2196 characters, which is consistent with a detailed report but not a full annual report. Therefore, the classification is AR with high confidence. FY 2017
2018-04-27 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding a change in accounting policies. It references specific accounting standards issued by the Ministry of Finance and details the rationale, impact, and approvals related to the accounting policy change. The document is relatively short (2118 characters) and does not contain actual financial statements or detailed financial data. Instead, it serves as a formal disclosure about the accounting policy change, including board and supervisory committee approvals and independent director opinions. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is not a report publication announcement since it contains substantive content about the policy change itself, not just a notice of report availability. The content fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2018-04-27 Chinese
关于2017年募集资金存放与使用情况的专项报告（已取消）
Capital/Financing Update Classification · 95% confidence The document is titled as a "2017 年募集资金存放与使用情况的专项报告" which translates to "2017 Special Report on the Deposit and Use of Raised Funds". It details the company's fundraising activities, including non-public stock issuances in 2013, 2014, and 2015, the amounts raised, the use of these funds, changes in investment projects, and compliance with regulatory requirements. The document references regulatory guidelines from the Shenzhen Stock Exchange and the China Securities Regulatory Commission regarding the management and use of raised funds. It includes detailed tables and explanations about the raised funds' allocation, usage, and management, as well as agreements with banks and securities firms for fund supervision. This type of report is a specialized disclosure focused on the management and use of capital raised by the company, which aligns with the category of Capital/Financing Update (CAP). It is not a full annual report, audit report, or earnings release, but a detailed update on fundraising and capital usage. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is CAP with high confidence.
2018-04-27 Chinese
西南证券股份有限公司关于公司使用部分闲置募集资金暂时补充流动资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Southwest Securities regarding the use of idle raised funds by Huabang Life Health Co., Ltd. It discusses the approval by the company's board, the regulatory compliance with securities laws, and the specifics of the raised funds usage. The document is not a financial report itself but a verification or audit opinion related to the use of funds. It does not contain comprehensive financial statements or quarterly/yearly financial data. The document length is 2811 characters, which is relatively short and focused on a specific regulatory compliance matter. This fits the category of an Audit Report / Information (AR), which includes standalone audit reports and verification opinions related to accounting and regulatory compliance, excluding full annual or interim reports.
2018-04-27 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.